Yair Fisher
Hoofd Techniek/Wetenschap/O&O bij Glixogen Therapeutics Ltd.
Profiel
Yair Fisher is currently the Chief Scientific Officer at GliXogen Therapeutics Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Actieve functies van Yair Fisher
| Bedrijven | Functie | Begin |
|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Hoofd Techniek/Wetenschap/O&O | 01-12-2018 |
Opleiding van Yair Fisher
| Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
